SCHEMBL6710064

SCHEMBL6710064

Cc1ccccc1CC(=O)Nc1cccc2cc(C(=O)Nc3ccc(Br)cc3-c3nnn[nH]3)[nH]c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
NSD2 O96028 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HIF1A Q16665 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
PARP14 Q460N5 1/20 0.37
GPR35 Q9HC97 3/20 0.36
POLB P06746 2/20 0.35
DHODH Q02127 1/20 0.35
TP53 P04637 2/20 0.35
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
MAP3K5 Q99683 1/20 0.35
PLA2G7 Q13093 1/20 0.35
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707757 0.91 KMT2A (0.49) ALDH1A1MEN1KMT2AHDAC3HDAC1
SCHEMBL6711793 0.91 CSNK1D (0.45) ALDH1A1MEN1KMT2AHDAC3HDAC1
SCHEMBL6714324 0.91 PARP14 (0.42) ALDH1A1MEN1KMT2APARP14GPR35
SCHEMBL6713328 0.91 NHERF1 (0.40) ALDH1A1NSD2MEN1KMT2AHDAC3
SCHEMBL6710320 0.89 PARP14 (0.39) NSD2MEN1KMT2AHIF1ANPSR1
SCHEMBL6711981 0.89 ALDH1A1 (0.39) ALDH1A1NSD2MEN1KMT2AHDAC3
SCHEMBL6713567 0.89 MEN1 (0.37) ALDH1A1MEN1KMT2AHDAC3HDAC1
SCHEMBL6709051 0.88 PARP14 (0.41) MEN1KMT2AHIF1ANPSR1RXFP1
SCHEMBL6710241 0.88 GPR35 (0.43) NSD2KMT2AHIF1ANPSR1RXFP1
SCHEMBL6710448 0.88 GPR35 (0.38) NSD2MEN1KMT2AHIF1ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 ALDH1A1 123/4885NSD2 3824/4885MEN1 4100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.